Intratumoral Targeted Hyperthermia Therapy (THT) for Cutaneous Metastatic Melanoma

计划入组 10 人 · 首次发布于 2025 年 3 月 11 日

Intratumoral Targeted Hyperthermia Therapy (THT) for Stage 3C/3D/4M1 Cutaneous Metastatic Melanoma

计划入组 10 人 · 首次发布于 2025 年 3 月 25 日

Image-guided Targeted Doxorubicin Delivery With Hyperthermia to Optimize Loco-regional Control in Breast Cancer

计划入组 12 人 · 首次发布于 2018 年 11 月 21 日

CD206 targeted Accurin (Pfizer)

gene therapy (Targeted Genetics (Genovo))

EGFRVIII-targeted CAR-T

TARGETED GENETICS CORPORATION

United States

TLA Targeted Immunotherapies AB

Sweden

Targeted Medical Pharma, Inc.

United States

Sona Nanotech's Targeted Hyperthermia Therapy Shows 38% Tumor Clearance in Colorectal Cancer Study

Sona Nanotech's Targeted Hyperthermia Therapy Shows 80% Response Rate in First-in-Human Melanoma Study

Sona Nanotech's Gold Nanorods Pass Critical Endotoxin Testing Ahead of First Human Cancer Trial